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The effect of perivitelline fluid (PVF) (0.019 mg/ml) on the stem cell viability extracted from human exfoliated 
deciduous teeth was assessed using LIVE/DEAD viability/cytotoxicity. It showed that PVF enhanced viability as observed 
by higher live cell percentage and a greater number of viable cells in the treated group for 3 days. The expression of selected 
cell cycle regulatory genes investigated using reverse transcriptase polymerase chain reaction (RT-PCR) for 21 days showed 
that CDKN2A, PTEN and TP53 expressed significantly higher in the treated group, suggesting that PVF enhanced SHED 
growth and proliferation. MDM2 expression remained at low levels in the treated group indicating that PVF did not result in 
tumorigenic growth. Low expression of apoptotic activator gene, BCL2L11 in treated group from day 1 until 14 with a 
sudden peak on day 21 was noted. This is deemed normal as the cells thrive to maintain homeostatic level at the 21st day of 
incubation.  
[Keywords: Cell proliferation, Gene expression, Horseshoe crab, Perivitelline fluid, Stem cells from human exfoliated 
deciduous teeth] 
Introduction 
Stem cells from human exfoliated deciduous teeth 
(SHED) possess a high proliferative ability
1
. SHED 
are also one of the highly clonogenic cells that can be 
differentiated into many types of cells viz. adipocytes, 
neural cells and odontoblasts
2
. Several studies have 





, and survive in 
mouse brain which even expresses neural markers
5
. 
SHED could be one of the pioneering candidates in 
the advancement of tissue engineering world not only 
because of their multipotent ability, but also due to 
their great alternative against the invasive procedure 
involved in the mesenchymal stem cells (MSCs) 
derived from bone marrow. Thus, exfoliated 
deciduous tooth has a great potential as resources for 
stem-cell therapies and tissue engineering. The 
present study aims to investigate the cell viability as 
well as the cell cycle regulatory genes’ expression of 
SHED due to the effect of perivitelline fluid (PVF). 
Horseshoe crabs are terrestrial organisms that have 
inhabited the world for more than 200 million years. 
They are versatile creatures as they have a much 
higher tolerance living in a broad range of 
temperatures and salinities compared to other marine 
organisms
6
. The predominant species of horseshoe 
crabs are four in number. The one found in North 
America is Limulus polyphemus while Tachypleus 
gigas, Tachypleus tridentatus and Carcinoscorpius 
rotundicauda are found in Southeast Asia
7
. In the 
past, humankind has discovered valuable biological 
resources obtained from the horseshoe crabs. One of it 
has been used in drugs and foods as a tester for 




PVF is derived from the fertilized egg of a 
horseshoe crab. The fluid that occupies the space in 
between the embryo and the outer envelope of the 
horseshoe crab is the PVF. PVF comprises numerous 
types of primitive proteins which are important and 
are capable of supplementing the growth as well the 
cell proliferation
9
. Numerous studies have explored 
the usage of PVF since 1970’s. Sugita & Sekiguchi
10
 
reported that PVF contained hemagglutinins and 
haemocyanins, proteins that play a crucial role in the 
process of embryogenesis. PVF is also suggested to 
help with the vertebrate’s embryogenesis as it 
influences the embryogenesis of chick at early 






. PVF also positively stimulates the 
development as well as organ differentiation like the 
brain and heart. Later, it was found that PVF 
contained lectin promotes the formation of cardiac 
myocytes in the embryos of the chicks
9
 which led to 
further the use of PVF in cell differentiation and 
organ regeneration. Stem cells were tested with the 
crude extract of PVF in order to observe the 
proliferation of cells as well as genotoxicity
12
 and it 
was concluded that PVF had no genotoxic effect. 
The PVF obtained from Tachypleus gigas 
(Malaysian horseshoe crabs) were treated on SHED to 
evaluate the cell cycle regulatory gene expression 
using reverse transcriptase polymerase chain reaction 
(RT-PCR). Cyclin-dependent kinase inhibitor 2A 
(CDKN2A), Bcl-2-like protein 11 (BCL2L11), 
phosphatase and tensin homolog (PTEN), mouse 
double minute 2 homolog (MDM2), and tumour 
protein p53 (TP53) were the genes selected for this 
purpose. The housekeeping gene glyceraldehyde-3-
phosphate dehydrogenase (GADPH) was used to 
normalize the expression of genes considered in this 
study. Besides, comparison of live cell percentage and 
cell morphology of SHED with and without PVF 
treatment was made using the Live/Dead 
viability/cytotoxicity kit intended for mammalian 
cells. The concentration of PVF extract used in this 




Materials and Methods 
Cell line and culture 
SHED were obtained from AllCells (USA, cat no. 
DP004F). They were cultured in mesenchymal stem 
cell (MSC) basal medium (AllCells, cat no. MSC-
002) supplemented with MSC stimulatory supplement 
(AllCells, cat no. MSC-003) and then incubated in a  
5 % CO2 humidified incubator at 37 °C until the cells 
reached confluence.  
 
Perivitelline fluid  
The horseshoe crab eggs (fertilized) were collected 
from a beach in Kuantan, Malaysia. The horseshoe 
crab eggs were brought to University Malaysia 
Terengganu (UMT) and were processed in the 
Aquatrop Laboratory and the eggs were incubated at 
29±1 °C in artificial incubator. Once the eggs became 
transparent and the movement of trilobite larvae was 
seen, they were further processed according to the 
method described
13
. After collection of PVF, the 
horseshoe crab eggs were released back into the sea. 
The PVF which was freeze dried was stored at a 
temperature of -70 °C. A cell viability study was 
conducted by Musa and colleagues on dental stem 




. They tested PVF at different 
concentrations by incubating the cells for a period of 
72 hours and calculated the percentages of relative 
cell viability in comparison with control wells (cell 
culture medium without extracts). Of all the 
concentrations tested, they found that the 
concentrations of 0.019 and 0.278 mg/ml of PVF 
produced the highest cell viability of 102.5 and 102 
%, respectively. Hence, 0.019 mg/ml concentration 
was selected to be used in this current study. In order 
to prepare the PVF extract, 1 ml of phosphate 
buffered saline (PBS) from Invitrogen, (UK) was 
added to the test sample and mixed which was further 
diluted to 0.019 mg/ml using the culture medium.  
A 0.2 μm syringe filter (Sartorius, UK) was used to 
sterilize the PVF extract. Fresh extract was prepared 
each time for the experiment. 
 
Gene expression analyses protocol 
PVF treatment  
The SHED were revived from the cryopreservation 
and sub-cultured twice before seeding for PVF treatment 
(0.019 mg/ml) at passage 6. The negative control group 
comprised SHED without any PVF treatment. Both the 
groups of SHED (treated and control) were incubated 
and harvested at day 1, 3, 7, 14 and 21. 
 
Total RNA extraction  
SHED were trypsinized from the flasks and 
prepared as a single suspension of cells. The cells 
were rinsed in PBS and a commercial kit for RNA 
extraction for mammalian cells, RN easy Mini Kit 
from QIAGEN (Germany, cat no. 74104) was used 
for extracting the total RNA. SHED were resuspended 
in alysis buffer and then homogenized using a QIA 
shredder column from QIAGEN (Germany, cat no. 
79654). The lysate was applied to RN easy column 
and then rinsed repeatedly using a series of buffers. 
This was followed by elution of the lysate into 
RNase-free deionized water. The total RNA was then 
quantified using UV spectrometry and checked for 
integrity and intactness by running them through the 
agarose gel electrophoresis. 
 
Synthesis of complementary DNA and reverse transcriptase 
polymerase chain reaction (RT-PCR)  
The 1st-strand complementary DNA (cDNA) from 
the total RNA was synthesized using the MMLV 




Reverse Transcriptase 1st-Strand cDNA Synthesis  
Kit from Epicentre (USA, cat no. MM070150).  
Next, RT-PCR was conducted as per the protocol 
using MyTaq™ HS Mix from Bioline (USA, cat no. 
BIO-25045). For each experiment, 1 µl (3 µg) of total 
RNA was used to run the RT-PCR in a 50 µl of final 
reaction volume. The gene primers that were designed 
and used in the current research are listed in Table 1. 
The thermal cycling parameters are as follows: 95 °C 
for 1 min for the activation of polymerase, 35 cycles 
of 95 °C for 15 sec, 54.2 °C for 10 sec (GADPH); 
58.0 °C for 15 sec (CDKN2A); 59.8 °C for 15 sec 
(BCL2L11); 58.0 °C for 15 sec (PTEN); 57.5 °C for 
15 sec (MDM2); 57.0 °C for 15 sec (TP53) and 72 °C 
for 10 sec. The cDNA synthesis and RT-PCR were 
performed in a Mastercycler nexus flat Thermal 
Cycler (Eppendorf, USA). SYBR Green (1 µl) was 
used to stain the PCR products separated on 1.0 % 
agarose gel and was visualized on a UV 
transilluminator (Biorad, USA). The images were 
photographed in an image analyser (Quantity One, 
USA). All the experiments were performed thrice and 
their band intensities were measured as Average 
Density Value (ADV) with Quantity One 1-D Image 
Analysis software (Bio-Rad, USA) which was 
normalized to the ADV values of glyceraldehyde-3-
phosphate dehydrogenase (GADPH). Mann Whitney 
statistical test was done to find out the significance of 
expression of genes between treated and control 
groups using SPSS software version 22.0. 
 
Live/Dead cell viability assay  
Fluorescence microscopy protocol 
SHED were cultured as described previously. Both 
the groups of SHED (treated and control) were 
cultured as sub confluent monolayers for 3 days on 
glass cover slips (sterile) by placing in 6 well-plates. 
After 1, 2 and 3 days, PBS was used to wash the cells 
twice in order to eliminate serum esterase activity in 
the media.  
LIVE/DEAD
®
 Viability/ Cytotoxicity Kit for 
mammalian cells from Thermo Fisher Scientific 
(USA, cat no. L3224) was used for this method. 100 
µl of the combined LIVE/DEAD assay reagents dyes 
was added on the cover slips containing the cells. The 
cells were then incubated for a period of 45 minutes 
in a covered dish at room temperature. Following the 
incubation, 10 µl of the LIVE/DEAD reagent dyes 
solution was then incorporated to a clean microscope 
slide. With the help of a fine-tipped forceps, the wet 
cover slips were then mounted quickly on the slide. 
This was followed by sealing the cover slips  
with a clear nail polish to avoid evaporation. The  
cells that were labelled were viewed under the 
fluorescence microscope immediately with fluoresce 
in isothiocyanate (FITC) (green emission) and 
propidium iodide (red emission) filters. The glass 
slides containing the cells were viewed thoroughly at 
all areas before the image was captured. The images 
of the cells were captured using Axio Vision 4.8 
software. Live cells were stained by membrane 
permeant and non-fluorescent calcein AM dye until 
the ubiquitous intracellular esterase eliminate the ester 
groups rendering the molecule fluorescent which then 
generates the green fluorescence. For the Excitation 
(max) 494 nm and Emission (max) 515 nm 
wavelengths, FITC filters were used, whereas, dead 
cells were stained by Ethidium homodimer-1 that 
labels cells with compromised membrane, then binds 
to DNA with high affinity and produces red 
fluorescence. The Excitation (max) 528 nm and 
Emission (max) 617 nm emitted red signals (similar 
to propidium iodide).  
 
Fluorescence microplate reader protocol 
The SHED were cultured as mentioned previously. 
Both groups of SHED (treated and control) were 
cultured in 96 well-plates for 3 days. 6 replicates were 
prepared for each group. The cells were analysed at 
day 1, 2 and 3 of incubation. On each day when the 
test was conducted, the cells were washed using PBS 
twice in order to remove serum esterase activity in the 
media. At the last wash, PBS was added to cover the 
bottom of the wells. The cells were then treated with 
Table 1 — Primer sequences for the different genes and their amplicon sizes 
Gene Accession No. Forward (5′-3′) Reverse (5′-3′) Product Size (bp) 
GAPDH NM_002046.5 CGACCACTTTGTCAAGCTCA AGGGGAGATTCAGTGTGGTG 203 
CDKN2A NM_058195.3 GAGAACATGGTGCGCAGGTT GCGCTGCCCATCATCATGA 219 
BCL2L11 NM_138621.4 CAGCACCCATGAGTTGTGAC CCTACACAAGAGAACCGCTG 401 
PTEN NM_000314.6 GCACAATATCCTTTTGAAGACC AGTGCCACTGGTCTATAATCC 323 
TP53 NM_001276760.1 GGAAGGAGACTTGCGTGTGG GCTCTCGGAACATCTCGAAGCG 440 
MDM2 NM_002392.5 GATTGGTTGGATCAGGATTCAG CATCATTGTCCGCAACACATG 439 




200 µl LIVE/DEAD cytotoxic agents. Incubation of 
the cells was done for 45 min at room temperature. 
The fluorescence reading of cells were taken using 
SkanIt software 2.4.3 for Varioskan Flash. Then, the 
measurement of fluorescence was done using 
fluorescence micro plate reader at 645 nm and 530 nm 
as per the formula given by the manufacturer, 
Invitrogen, (USA). 
Dead cells are characterized by intense 
fluorescence at > 600 nm and little fluorescence 
around 530 nm. The live cell percentage was 
calculated based on the fluorescence readings as given 
below: 
 
% Live Cells = 
𝐹(530)𝑠𝑎𝑚  – 𝐹(530)𝑚𝑖𝑛  
𝐹 530 𝑚𝑎𝑥 −𝐹 530 𝑚𝑖𝑛
 X 100 % 
 
The dead cell percentage was calculated based on 
the fluorescence readings as given below: 
 
% Dead Cells =
𝐹(645)𝑠𝑎𝑚  – 𝐹(645)𝑚𝑖𝑛  
𝐹 645 𝑚𝑎𝑥 −𝐹 645 𝑚𝑖𝑛
 X 100 % 
 
Results  
Gene expression analyses 
The gene expression of CDKN2A, PTEN, TP53 and 
MDM2 (cell cycle regulatory genes) and BCL2L11 
(apoptosis regulator gene) were analysed for a period 
of 21 days at day 1, 3, 7, 14 and 21. The expression of 
these genes was normalized to GADPH. The ADV 
was recorded in triplicates for each gene expressed in 
PVF treated and untreated SHED for 21 days  
(Table 2). The housekeeping gene, GAPDH showed 
constant expression throughout for 21 days for both 
the SHED treated with PVF and the control SHED 
(Fig. 1a). 
The expression of CDKN2A, PTEN and TP53 in 
the PVF treated SHED appeared to be in a similar 
pattern (Figs. 1b, d, f; and 2a – c). It was observed 
that these 3 genes started to gradually increase in 
expression from day 3 onwards to day 14, and slightly 
decreased on day 21. On the contrary, the expression 
of CDKN2A, PTEN and TP53 in SHED control group 
gradually decreased from day 3 till the 21
st
 day (Figs. 
2a – c). The significance in the expression of the 
genes between both the groups of SHED were 
analysed by Mann Whitney test (Table 2). The 
expression of these genes showed significant 
difference (p ≤ 0.05) beginning from day 3 until day 
21 in the PVF treated SHED in comparison to the 
control. On the other hand, MDM2 showed relatively 
lower expression in the PVF treated group than in the 
control group (Fig. 1e). MDM2 was highly expressed 
in the control at day 3 and 7 (Fig. 2d). The expression 
of MDM2 however increased drastically in PVF 
treated group at day 14 but then dropped significantly  
Table 2 — Normalized average density values (ADV) of gene expressions between control and perivitelline fluid treated SHED  
on day 1, 3, 7, 14 and 21 
 
Genes 
ADV Day 1 ADV Day 3 ADV Day 7 ADV Day 14 ADV Day 21 
Control Treated p-value Control Treated p-value Control Treated p-value Control Treated p-value Control Treated p-value 
CDKN2A 0.249 0.608 0.127 1.850 0.315 *0.050 2.191 0.574 *0.050 1.198 1.889 *0.050 0.126 1.988 *0.050 
BCL2L11 0.513 0.519 0.827 0.631 0.224 *0.050 0.532 0 *0.037 0.595 0 *0.037 0.241 0.989 *0.046 
PTEN 0.529 1.046 *0.050 1.346 0.548 *0.050 1.587 0.672 *0.050 0.589 1.116 *0.050 0.529 0.773 0.513 
MDM2 0 0.553 *0.037 2.221 0.782 *0.050 1.595 0 *0.037 0.821 2.050 *0.050 0 0.420 *0.037 
TP53 0 0.558 *0.037 0.460 0.232 *0.050 1.505 0.341 *0.046 0.643 1.037 *0.050 0 0.439 *0.037 
Treated: PVF treated group; * Significant difference in gene expression between control and PVF treated groups (p ≤ 0.05) 
 
 
Fig. 1 — Expression of cell cycle regulatory genes in the control 
and perivitelline fluid treated SHED on day 1, 3, 7, 14 and 21  
(A: GAPDH, B:CDKN2A, C: BCL2L11, D: PTEN, E: MDM2, and 
F: TP53). CD: Control SHED; and TD: PVF treated SHED 






Fig. 2 — Normalized expression of cell cycle regulatory genes in 
control and perivitelline fluid treated SHED on day 1, 3, 7, 14 and 
21 (A: CDKN2A, B: TP53, C: PTEN, D: MDM2, and E: 
BCL2L11). * shows significant difference between control and 
treated group at p ≤ 0.05 
 
at day 21. Both groups showed low expression of 
MDM2 at the end of the experiment (Fig. 2d). 
BCL2L11 expression was either lesser or absent 
completely in the group treated with PVF in 
comparison to the control group from day 1 until day 
14 (Fig. 1c). However, at day 21, expression of 
BCL2L11 drastically spiked in the PVF treated group  
while the expression in the control remained low as 
shown in Figure 2e. 
 
Live/Dead cell viability  
This experiment was carried out to study the effects 
of PVF treated on the viability of SHED. The number of 
cells seeded onto the glass slides at the beginning of the 
experiment was kept constant for both groups which 
were 6000 cells. The cells were viewed on each day for 
3 days. Cells which were live produced an intense 
uniform green fluorescence (ex/em ~495 nm/ ~515 nm) 
while cells which were dead emitted bright red-orange 
fluorescence (ex/em ~495 nm/ ~635 nm). Figure 3 
shows that the viability of cells between both groups did 
not exhibit any significant difference at day 1 and 2. 
However, at day 3, a cluster of dead cells were detected 
in the control group as shown in image E in Figure 3. 
This could be due to the overcrowding of cells on the 
glass slide that led to cell senescence or death. However, 
in the PVF treated group, SHED appeared to be growing 
well and viable with minimum number of dead cells 
compared to the control. 
Table 3 shows the fluorescence readings at 645 and 
530 nm in control and treated groups at 1, 2 and 3 
days of incubation. The values of A, B, C, D, E, F, G 
and H were incorporated into the formula to obtain 
percentage of live and dead cells. Live cell percentage 
in control group decreased from day 1 to 3, while the 
dead cells increased gradually from day 1 to 3  
(Fig. 4). In contrast, the percentage of live cells in 
SHED with PVF treatment remained high which was 
above 90 % until day 3, with a lower percentage of 
dead cells in comparison to the control group as 
shown in Figures 4a & b.  
 
Discussion 
Investigating and comparing the expression of 
genes that regulates cell cycle is vital in grasping 
clues at the molecular level on how certain treatments 
affect the cell cycle and growth of cells. This is 
important to determine the potential of PVF as a 
growth supplement for tissue engineering purposes in 
the future. PVF is abundant in important primitive 
proteins such as hemagglutinins, haemocyanins and 
lectins which are deemed important in supporting 
embryogenesis
10,11
. PVF has also been widely studied 
previously and shown to support organ regeneration 
in chicks
10




In the current study, the genes CDKN2A, PTEN, 
MDM2, TP53 and BCL2L11 were selected because of  







Fig. 3 — Fluorescence microscopy of SHED treated with perivitelline fluid (B, D, F) and control (A, C, E) at day 1, 2 and 3, scale  
bar = 5 µm and 10 µm. Live and dead cells are shown by the green and red-orange fluorescence respectively 
 
Table 3 — Fluorescence readings at wavelengths of 645 nm and  
530 nm in control and perivitelline fluid treated SHED groups at  















A 0.010 0.140 0.077 0.274 0.149 0.424 
B 0.765 0.960 1.099 0.757 1.347 0.741 
C 0.073 1.664 0.251 1.515 0.413 1.199 
D 0.005 0.110 0.034 0.214 0.067 0.341 
E 2.055 0.050 1.940 1.780 1.767 1.616 
F 0.700 0.967 0.912 0.721 1.215 0.657 
G 0 0 0 0 0 0 
H 0 0 0 0 0 0 
Please refer to the materials and methods section for the 
annotations of A, B, C, D, E, F, G and H 
 
their significant role in regulating cell cycle as well as 
in apoptosis, respectively. CDKN2A regulates cell 
cycle arrest at G1 stage encoding two important 
tumour suppressor proteins, namely p16(INK4a) and 
p14(ARF)
14 
which play a crucial part in the 
retinoblastoma (Rb) protein and p53 pathways, 
respectively
15
. p16(INK4a) as well as p14(ARF) work 
differently at the end of G1 phase in initiating cell 
cycle rest, thus halting the cells from entering S 
phase
16
. Moreover, the relationship between 
CDKN2A, MDM2 and TP53 in regulating cell cycle 
progression at G1 checkpoint is crucial to be 
understood as these three genes are tightly 
interconnected to one another. As reported in previous  
 
 
Fig. 4 — Percentage of live (A) and dead (B) cells in control and 
perivitelline fluid treated groups for 3 consecutive days (Values 
from Table 3 were incorporated into the given formula to obtain 
the percentage (%) of live and dead cells) 
 
studies it is well known that the p14(ARF) protein 
which is produced by CDKN2A promotes activation 




of p53 protein, which in turn leads to inactivation of 
MDM2 protein
17,18
. Also, TP53 is often activated as a 
response to DNA damage
19
. This is followed by the 
increase in MDM2 levels as both genes have a 
negative autoregulatory feedback. This phenomenon 
results in G1 arrest
20
. Therefore, expression of MDM2 
at a higher level would incline to apoptosis
20
. PTEN, 
on the other hand, catalyses dephosphorylation of 3′ 
phosphate of the inositol ring in PIP3 which results in 
the biphosphate product PIP2 (PtdIns(4,5)P2).  
The dephosphorylation step plays an important role as 
it results in the inhibition of AKT signalling 
pathway
21
. Yamada & Araki
21
 have also demonstrated 
the significance of PTEN in mediating cellular 
senescence as well as the control of cell growth. The 
expression of apoptotic regulator gene, BCL2L11, 
which encodes for BH3 proteins functions as 
apoptotic activator when it interacts with other sets of 
proteins from the BCL-2 family. Previous studies 
have demonstrated that over expression of BIM 
protein will trigger apoptosis by the activation of cell 




The expression of these genes was analysed in PVF 
treated and control SHED at passage 6 for a period of 
21 days (day 1, 3, 7, 14 and 21). In general, low 
passage and high passage can affect the phenotype 
and gene expression characteristics of cells. Also, 
high passage cell lines do not represent reliable 





 reported that generally, cells from 
passage 4-6 are stable with the cells reaching 
confluence faster. Hence, passage 6 was selected for 
the current study. The choice of number of days was 
based on previous studies that have conducted gene 
expression analyses on day 1, 3, 7, 14 and 21
(refs. 25,26)
 
since such a sequence would enable in evaluating the 
pattern of gene expression at different time points 
between the experimental and control groups. 
CDKN2A gene encodes tumour suppressor 
proteins which are p16(INK4a) and p14(ARF)
27
. The 
tumour suppressor proteins produced by CDKN2A 
have specific roles that work together and function in 
controlling cell cycle G1. The product of α transcript, 
p16INK4a, inhibits phosphorylation of Rb protein 
caused by the cyclin-dependent kinases, namely 
CDK4 and CDK6 leading to cell cycle arrest in G1, 
while, p14ARF, the product of the human CDKN2Aβ 
transcript, causes cell cycle arrest at both G1 and 
G2/M by activating a p53 response which results in 
the elevated levels of MDM2 and p21CIP1
(ref. 17)
. 
CDKN2A has been mutated or deleted in a many types 
of tumours such as head and neck squamous cell 
carcinoma
28
. The functions of CDKN2A are often 
altered in cancers whereby it involves in significant 
reduction on amounts of p16(INK4a) or p14(ARF) 
proteins. Absence of these tumour suppressor proteins 
will lead to cells growing and dividing without 
control, hence leading to the onset of cancer. Based 
on the results of the current study, CDKN2A 
expression was consistently present in the PVF treated 
group. It was noted that CDKN2A expression 
increased gradually in PVF treated group from day 3 
to day 21. The expression in PVF treated group was 
also significantly higher as compared to the control 
group which portrayed a decline in expression as it 
approached the 21
st
 day of incubation. Thus, this 
suggests that the proliferation activity of SHED is 
enhanced in the presence of PVF.  
PTEN is also one of the common tumour 
suppressor genes whereby its deregulation and 
disruption are often illustrated in various types of 
cancers such as Cowden disease and breast 
carcinomas
29,30
. PTEN is involved tightly with a series 
of signalling proteins; regulating a plethora of cellular 
processes including growth, survival, proliferation, 
motility, and polarity
31
. PTEN encodes lipid 
phosphatase a ubiquitous regulator for cellular PI 
(phosphoinositide) 3-kinase signalling pathway 




Evidences have shown that the signals emitted by 
PtdIns(3,4,5)P3 is vital in mediating downstream 
signalling in directing many cell physiological 
processes, namely, proliferation of cells, cell survival, 
growth as well as motility. The level of the lipid, 
PtdIns(3,4,5)P3 will commonly intensify prior to 
receiving external cellular stimuli such as growth 
factors. This is proven to be true when the results of 
this study showed the significant increase in PTEN 
expression when PVF treatment was given to SHED. 
We hypothesise that the PVF might contain growth 
stimulatory factors which explain the intensified 
expression of PTEN in treated groups compared to the 
control.  
Another tumour suppressor gene that was studied is 
TP53. Tumour suppressor p53 is an important 
transcription factor that has an important role in 
regulating cell cycle, DNA repair, apoptosis, 
senescence, and angiogenesis
32-34
. However, MDM2 is 




a necessary regulator of p53 in the case of normal 
cells where p53 creates an autoregulatory feedback 
loop with the oncogene MDM2 proteins
35
. Besides 
that, MDM2 is a proto-oncogene whereby the encoded 
protein promotes tumour formation by targeting the 
tumour suppressor p53 proteins for proteasomal 
degradation. The amplification or over expression of 
MDM2 has been found in large cases of various 
cancers and was first detected in sarcomas that retain 
the wild type p53
36
. Our study showed low expression 
of MDM2 in PVF treated group along the whole 
experiment time frame except for a sudden peak on 
day 14. This could probably be due to the actively 
increasing number of cells proliferating in the PVF 
treated group during that time. MDM2 expression 
however remained at low levels again on day 21 
which strongly suggests that PVF treatment does not 
lead to tumorigenic growth of cells in SHED. It is 
important to note that MDM2 expression should be 
kept at low levels as over expression of this gene 
could result in tumour growth. This is due to the fact 
that it can inhibit the DNA double-strand break repair 
that is mediated through a novel direct interaction 




BCL2L11 is a member of BCL-2 protein family. 
TheBCL-2 family members can create hetero- or 
homodimers acting as an anti- or pro-apoptotic 
regulator which are involved in a variety of cellular 
activities. The protein encoded by this gene has a Bcl-
2 homology domain 3 (BH3) that has been made 
known to interact with the other members of BCL-2 
protein family as well as to act as an apoptotic 
activator
38
. Apoptosis is an essential cellular 
haemostatic mechanism that keeps cell population in 
balance and prevents cell population from 
uncontrolled increase in growth
39
. If cell death is 
repressed, cell accumulation takes place that could 
lead to many types of cancers and autoimmune 
diseases
40,41
. Based on the results of our study, 
BCL2L11 expression in PVF treated group was 
maintained at low levels from day 1 to 3 but 
disappeared completely on day 7 and 14. Low 
expression levels of BCL2L11 at an earlier stage of 
incubation suggest that the cells are actively 
proliferating at the moment with minimal signs of cell 
death. However, on the 21
st
 day, a sudden spike in 
BCL2L11 expression was detected in PVF treated 
group. This could be due to the overcrowding of cells 
in the confined culture flask treated group at day 21 
which might induce the process of apoptosis/cell 
death as suggested
40
. Their findings suggested that 
during homeostatic turnover, the growth as well as the 
division of epithelial cells on confined substratum 
could result in overcrowding which could eventually 




Besides analysing the gene expression profiles,  
the cell viability of SHED using fluorescence 
microscopy and fluorescence microplate method is 
also investigated in the current study. The 
LIVE/DEAD
®
 Viability/Cytotoxicity Assay Kit  
was employed in this study to conduct the experiment 
because it provides an effortless, reliable and sensitive 
fluorescence-based method in order to determine the 
viability of both adherent and non-adherent cells.  
The kit contains two probes, namely calcein AM and 
ethidium homodimer-1 that distinguishes the live  
cells from the dead cells by producing intense 
uniform green fluorescence in cells that are live 
(ex/em ~495 nm/ ~515 nm). On the other hand, dead 
cells are characterized by the production of a bright 
red-orange fluorescence (ex/em ~495 nm/ ~635 nm). 
The findings of this study suggested that incubating 
the SHED with PVF for 3 days gave higher cell 
viability in comparison to the control as shown by 
higher percentage of live cells. Besides that, the 
fluorescence microscopy images showed viable 
SHED for all 3 days of incubation with minimal signs 
of cell death. 
 
Conclusion 
Treatment with 0.019 mg/ml of PVF on SHED 
enhanced cell cycle and growth as shown by a 
significant increase in the expression of CDKN2A, 
PTEN and TP53 genes. Also, PVF treatment did not 
cause any tumorigenicity as supported by the MDM2 
expression that remained low and controlled 
throughout the 21 days of incubation. In contrast, it is 
also hypothesized that due to the actively proliferating 
SHED with PVF treatment inside a confined culture 
flask environment for a longer period might cause the 
cells to undergo apoptosis as shown by the sudden 
spike in BCL2L11 expression on 21
st
 day of 
incubation. PVF treatment also showed higher cell 
viability of SHED as shown by fluorescence 
microscopy and microplate reader. It can be 
concluded that PVF from horseshoe crab can serve as 
a beneficial material in stem cell culture and 
regenerative medicine. 
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